Refractory acute myeloid leukemia Clinical Trials

Delta Trials records 124 clinical trials for Refractory acute myeloid leukemia in its publicly accessible dataset. From the full dataset, 44 actively seeking eligible participants and 32 trials have reached completion. This research is conducted across 93 study locations around the world. An additional 48 trials are active but not currently open for enrollment. Since 2020, 20 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.